Dr M. F. Perutz, chairman of the governing board of the MRC Molecular Biology Laboratory, Cambridge, offers his views on the Rothschild report.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Health and the Medical Research Council. Nature 235, 191–192 (1972). https://doi.org/10.1038/235191a0
Issue Date:
DOI: https://doi.org/10.1038/235191a0
This article is cited by
-
Evolving Approaches of Hematopoietic Stem Cell–Based Therapies to Induce Tolerance to Organ Transplants: The Long Road to Tolerance
Clinical Pharmacology & Therapeutics (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.